 Multiple myeloma lymphocytes plasma cell-associated antigens indicator poor survival multiple myeloma MM increase lymphocytes plasma cell-associated antigens PCAA prognostic significance study immunologic phenotype peripheral blood lymphocytes panel monoclonal antibodies natural killer lymphocytes PCAA MM patients diagnosis remission relapse monoclonal gammopathy undetermined significance MGUS normal controls significant phenotypic alteration MGUS MM number lymphocytes normal range diagnosis subsequent phases ratio decrease relapse due reduction expansion subset suppressor lymphocytes diagnosis MGUS increase relapse correlation PCAA expression disease activity prognostic significance increased PCAA survival analysis patients diagnosis cutoff positive lymphocytes Median survival patients high values months months low values